
A message from John P. Roberts, M.D.
Professor & Chief, Division of Transplant Surgery, UCSF Liver Transplant Program
A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.
The FDA has approved two new medications, Incivek and Victrelis, for treatment of hepatitis C. These drugs mark a new direction in treatment and significant improvement over the current standard of care.